Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 70

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 70
---
 Enfusion

Clearwater’s and Enfusion’s businesses are and will be subject to the risks described above. In addition, Clearwater and Enfusion
are, and will continue to be, subject to the risks described in Clearwater’s Annual Report for the fiscal year ended December 31, 2023 and Enfusion’s Annual Report on Form 10-K for the fiscal

40

year ended December 31, 2023, as updated by subsequent Quarterly Reports on Form 10-Q and Current Reports on Form
8-K, all of which are filed with the SEC and incorporated by reference into this Proxy Statement/Prospectus. The risks described above and in those filings represent all known material risks with respect to
Clearwater’s and Enfusion’s businesses. See the section titled “Where You Can Find More Information” for the location of information incorporated by reference into this Proxy Statement/Prospectus.

41

INFORMATION ABOUT ENFUSION

Enfusion, Inc. and Enfusion Ltd. LLC

Enfusion, Inc., a Delaware corporation, is a global, high-growth, software-as-a-service provider focused on transforming the investment management industry. The products and services that comprise its solution are designed to eliminate technology and information
barriers, empowering investment managers to confidently make and execute better-informed investment decisions in real time. Enfusion’s platform simplifies investment and operational workflows by unifying mission-critical systems and coalescing
data into a single dataset, which allows stakeholders throughout an entire client organization to interact more effectively with one another across the investment management lifecycle. Enfusion Common Stock trades on the NYSE under the symbol
“ENFN.” Enfusion is a holding company, and its only material asset is its direct and indirect ownership interests and management rights in Enfusion Ltd. LLC, a Delaware limited liability company, through which Enfusion conducts
substantially all of its business. Enfusion’s principal executive offices are located at 125 South Clark Street, Suite 750, Chicago, IL 60603.

42

INFORMATION ABOUT CLEARWATER

Clearwater Analytics Holdings, Inc.

Clearwater brings transparency to the opaque world of investment accounting and analytics with what Clearwater believes is the industry’s
most trusted and innovative single instance, multi-tenant technology platform. Clearwater’s cloud-native software allows clients to radically simplify their investment accounting operations, enabling them to focus on higher-value business
functions such as asset allocation strategy and investment selection. Clearwater’s platform provides comprehensive accounting, data and advanced